InsiderTrades

Form 4 for TMO Thermo Fisher Scientific

Accepted 2025-09-02 00:00:00 ET · period of report 2025-08-28 · accession 0000097745-25-000124 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-09-02 2025-08-29 TMO Holmes Joseph R. VP, CAO S - Sale+OE $492.63 -385 2,604 -13% -$189.7K
D 2025-09-02 2025-08-29 TMO Holmes Joseph R. VP, CAO M - OptEx $253.99 +385 2,704 +17% +$97.8K
DM 2025-09-02 2025-08-28 TMO Holmes Joseph R. VP, CAO F - Tax $489.74 -36.99 2,319 -2% -$18.1K
D 2025-09-02 2025-08-29 TMO Holmes Joseph R. VP, CAO M - OptEx $0.00 -385 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-08-29 S D 285 $492.63 2,318.98 D — —
2 Common Common Stock 2025-08-29 S D 100 $492.62 2,603.98 D — —
3 Common Common Stock 2025-08-29 M A 385 $253.99 2,703.98 D — —
4 Common Common Stock 2025-08-28 F D 10.86 $489.74 2,326.03 D — —
5 Common Common Stock 2025-08-28 F D 10.57 $489.74 2,336.89 D — —
6 Common Common Stock 2025-08-28 F D 8.51 $489.74 2,347.45 D — — (F1) Includes 54.846 shares acquired under the Issuer's employees' stock purchase plan on May 15, 2025.
7 Common Common Stock 2025-08-28 F D 7.05 $489.74 2,318.98 D — —
8 Derivative Stock Option (Right to Buy) 2025-08-29 M D 385 $0.00 0 D $253.99 · — to 2026-02-26 385 Common Stock (F2) The option vested in four equal installments on February 26, 2020, 2021, 2022, and 2023.